LONDON BROKER RATINGS: Experian on JPMorgan focus list at 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations on Thursday morning and on Wednesday: Read More
| Price | 160.85p on 26-12-2025 at 05:12:22 |
|---|---|
| Change | 0.00p 0% |
| Buy | 162.00p |
| Sell | 161.20p |
| Last Trade: | Sell 379,007.00 at 160.85p |
| Day's Volume: | 0 |
| Last Close: | 160.85p |
| Open: | 0.00p |
| ISIN: | LU1072616219 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 154.00p - 378.50p |
| Market Capitalisation: | £1.62b |
| VWAP: | 0.00p |
| Shares in Issue: | 1.01b |
B&M (BME) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 379,007 | 160.85p | Uncrossing Trade |
12:35:28 - 24-Dec-25 |
| Buy* | 916 | 161.60p | Automatic Execution |
12:29:54 - 24-Dec-25 |
| Buy* | 105 | 161.60p | Automatic Execution |
12:29:54 - 24-Dec-25 |
| Buy* | 10 | 161.55p | SI Trade |
12:29:04 - 24-Dec-25 |
| Buy* | 572 | 161.55p | Automatic Execution |
12:29:04 - 24-Dec-25 |
| Unknown* | 0 | 161.60p | OTC Trade |
12:28:36 - 24-Dec-25 |
| Unknown* | 0 | 161.60p | OTC Trade |
12:28:36 - 24-Dec-25 |
| Unknown* | 0 | 161.60p | OTC Trade |
12:28:36 - 24-Dec-25 |
| Unknown* | 0 | 161.60p | OTC Trade |
12:28:35 - 24-Dec-25 |
| Unknown* | 1 | 161.60p | OTC Trade |
12:28:35 - 24-Dec-25 |
B&M (BME) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Dec 2025 2:00 pm | RNS | Timing of Q3 FY26 Trading Statement |
| 23rd Dec 2025 2:00 pm | RNS | Timing of Q3 FY26 Trading Statement |
| 19th Dec 2025 9:00 am | RNS | Major Holding in Company - TR1 |
| 19th Dec 2025 9:00 am | RNS | Major Holding in Company - TR1 |
| 4th Dec 2025 10:00 am | RNS | Major Holding in Company - TR1 |
| 28th Nov 2025 11:00 am | RNS | Major Holding in Company - TR1 |
| 26th Nov 2025 9:30 am | RNS | Major Holding in Company TR1 |
| 24th Nov 2025 2:30 pm | RNS | Major Holding in Company- TR1 |
| 20th Nov 2025 4:00 pm | RNS | CEO Purchase of shares |
| 20th Nov 2025 11:00 am | RNS | CEO Purchase of Shares |